Emerging Therapies in Relapsing-Remitting Multiple Sclerosis

By  

Reviews on Recent Clinical Trials, Vol. 5, Iss. 3, 2010-09 ,pp. : 179-188

Bentham Science Publishers

Access to resources Recommend Favorite

Ten‐year prognosis in multiple sclerosis: a better outcome in relapsing−remitting patients but not in primary progressive patients

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 3, 2015-03 ,pp. : 507-e35

John Wiley & Sons Inc

Access to resources Recommend Favorite

Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial

By Robinson D.   Zhao N.   Gathany T.   Kim L.-L.   Cella D.   Revicki D.  

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1121-1130

Informa Healthcare

Access to resources Recommend Favorite

Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing–remitting multiple sclerosis

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 3, 2015-03 ,pp. : 564-569

John Wiley & Sons Inc

Access to resources Recommend Favorite

PK and PD of peginterferon beta‐1a in multiple sclerosis patients

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 3, 2015-03 ,pp. : 514-522

John Wiley & Sons Inc

Access to resources Recommend Favorite